Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-04-13 @ 3:58 PM
Study NCT ID:
NCT06673693
Status:
RECRUITING
Last Update Posted:
2025-04-16
First Post:
2024-10-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With SBRT for the Treatment of Head and Neck Squamous Cell Carcinoma
Sponsor:
Organization: